baber/WOPTO huggingface dataset:
Patent CA-2545346-A1 (CA)
Inventor: GOLDBERG MARIA
IPC: G06Q30/02
Filed: 2006-04-28
Abstract: A system is provided for managing incoming communications placed in response to advertising, online content, and/or special service numbers.  Information extracted from incoming communications can be received by a system server and cross-referenced with a database to obtain cross-referenced customer information pertaining to previous customer communications in the form of online communications, telephone calls, and/or in person customer meetings. The cross-referenced customer information can be passed to a client workstation and displayed to the user in the form of an industry-specific template formatted in accordance with the business needs of the user. The template can be automatically populated with the cross-referenced customer information.   The user can view and update the customer information, thereby maintaining a retrievable record of the communication. With regard to the multi-housing industry in particular, customer information can be displayed in the form of a guest card template and/or a service card template.
Patent CA-2545557-A1 (CA)
Inventor: GALIPEAU JACQUES
IPC: A61K35/15
Filed: 2006-05-02
Abstract: There is provided a stromal antigen-presenting cell capable of antigen presentation in the context of MHC II. When stimulated with IFN.gamma. the stromal cell expresses B7-H1 and/or CD80. These stromal cells can be used to generate an immune response in an animal.
Patent CA-2546502-A1 (CA)
Title: A method for gene amplification
Inventor: HORIUCHI TAKASHI
IPC: C12P21/02
Filed: 2004-11-12
Abstract: [PROBLEMS] To provide a double-stranded DNA for amplifying a gene at a high speed and a method of amplifying a gene and a method of producing a protein using the same. [MEANS FOR SOLVING PROBLEMS] A system of artificially amplifying a gene at a high speed based on the gene replication (BIR: break-induced replication) system in vivo is constructed. High-speed gene amplification is triggered by transferring a double-stranded DNA having the sequences A-B-C and A~-B~-C~ or the reverse sequence of A~-B~-C~ (wherein A  and A~ represent double-stranded DNA fragments capable of undergoing homologous recombination with each other one of which has a sequence reverse to the other; B and B~ represent amplification parts at least one of which contains a gene to be amplified; and C and C~ represent double-stranded DNA  fragments capable of undergoing homologous recombination with each other one of which has a sequence reverse to the other; provided that an arbitrary DNA  sequence may be inserted between them and B and B~ may be omitted (in this case, A or C may serve as a gene to be amplified) into a chromosome or a plasmid, and inducing the expression of an enzyme which arbitrarily cleaves a specific sequence so as to cause the occurrence of cleavage at a specific site.
Patent CA-2549516-A1 (CA)
Title: Percutaneous absorption-type pharmaceutical preparation
Inventor: SEKIYA JUNICHI
IPC: A61K9/70
Filed: 2006-06-06
Abstract: A stable percutaneous absorption-type pharmaceutical preparation for percutaneous administration of selegiline or selegiline hydrochloride, which does not suffer a decrease in the cohesive force of the adhesive layer therein even in the presence of sweat components due to perspiration during wear and which is free from cohesive failure and resultant adhesive remaining when stripped off, is provided. A percutaneous absorption-type pharmaceutical preparation which comprises: a support; and an adhesive layer containing a metal chloride, an adhesive and at least one of (-)-(R)-N,.alpha.-dimethyl-N-2-propynylphenethylamine and its hydrochloride, wherein the adhesive layer is subjected to a crosslinking treatment.
Patent CA-2550653-A1 (CA)
Inventor: DAVIS EDGAR
IPC: B65D25/20
Filed: 2006-06-19
Abstract: A display panel for associating a promotional item with a product is provided.     The display panel includes wells to retain the promotional item in a fixed location. The display panel also includes side attachment means for adhering the panel to the associated product.
Patent CA-2552586-A1 (CA)
Title: Improved gate valve sealing structure
Inventor: GAGAS MICHAEL
IPC: E03B7/07
Filed: 2006-07-20
Abstract: An improved liquid infiltration adapting structure for preventing liquid infiltration around a gate valve box. The structure has an annular tube structure that is tapered to more easily receive a mating pipe. The tube structure may also comprise at least one bead for further securing the mating pipe. The adapting structure is also improved by providing a stepped inner flange for ease of installing the structure around the gate valve box.
Patent CA-2553425-A1 (CA)
Title: Spinal implant construct and method for implantation
Inventor: MOLZ FRED J IV
IPC: A61F2/00
Filed: 2005-01-12
Abstract: A spinal construct (16) and method for implantation is provided which utilizes a spinal implant (17) adapted for insertion within an intervertebral space between an adjacent pair of vertebral bodies (11, 12), and an elongate member (26) adapted for anchoring to the adjacent vertebral bodies (11, 12). The spinal implant (17) defines a first transverse dimension (A) and a different second transverse dimension (B), and is initially inserted into the intervertebral space while in a first operational configuration wherein the first transverse dimension (A) extends along the height of the intervertebral space. The elongate member (26) is anchored to the vertebral bodies (11, 12) to establish and maintain a select height of the intervertebral space. The spinal implant (17) is then rotated to a second operational configuration wherein the second transverse dimension (B) extends along the height of the intervertebral space. The elongate member (26) serves to maintain the select height of the intervertebral space to provide a controlled amount of compression onto the spinal implant (17) and/or a bone growth promoting material contained therein. The elongate member (26) also serves to resist tensile loads during extensional movement of the vertebral bodies (11, 12) to maintain the vertebral endplates in intimate contact with the spinal implant (17).
Patent CA-2553731-A1 (CA)
Title: Production of a monoclonal antibody in a heterokaryon fungus or in a fungal host cell
Inventor: WAHLBOM FREDRIK
IPC: C07K16/00
Filed: 2005-01-20
Abstract: The present invention relates to methods for producing a monoclonal antibody in a hetero-karyon fungus or in a fungal host cell. Furthermore, it also relates to a nucleic acid construct a first nucleic acid sequence encoding a light chain of an antibody and a third nucleic acid se-quence encoding a signal peptide heterologous to the first nucleic acid sequence, a nucleic acid construct comprising a first nucleic acid sequence encoding a heavy chain of an antibody and a third nucleic acid sequence encoding a signal peptide heterologous to the first nucleic acid sequence, a nucleic acid construct comprising a first nucleic acid sequence encoding a light chain of an antibody and a second nucleic acid sequence encoding a cellulose binding domain, and a nucleic acid construct comprising a first nucleic acid sequence encoding a heavy chain of an antibody and a second nucleic acid sequence encoding a cellulose binding domain.
Patent CA-2554084-A1 (CA)
Inventor: RUFF BRENDAN
IPC: C11C5/00
Filed: 2005-02-04
Abstract: A scented pellet comprising a suitable bulk material such as wax and a scent ed material for introducing scent to the melt pool of a candle. The pellet is s o constructed that it melts and mixes into the melt pool of the candle for the purpose of releasing the scented material within the pellet into the melt po ol as the bulk material of the pellet melts. The scent is mixed with the candle melt pool giving the candle a scent while the candle burns.
Patent CA-2558169-A1 (CA)
Inventor: ELICEIRI BRIAN
IPC: A61K31/519
Filed: 2005-03-15
Abstract: Myocardial infarction in a mammal is treated by administering to the mammal a therapeutically effective amount of a chemical Src family tyrosine kinase protein inhibitor and the use of such inhibitor compounds for the preparation of a medicament for treating myocardial infarction. Myocardial infarction can be prevented by administering to the mammal a prophylactic amount of the inhibitor. The inhibitor preferably is an inhibitor of Src protein selected from the group consisting of a pyrazolopyrimidine class Src family tyrosine kinase inhibitor, a macrocyclic dienone class Src family tyrosine kinase inhibitor, a pyrido[2,3-d]pyrimidine class Src family tyrosine kinase inhibitor, a 4-anilino-3-quinolinecarbonitrile class Src family tyrosine kinase inhibitor, and a mixture thereof. In a particularly preferred embodiment, the Src family tyrosine kinase inhibitor is an ATP-competitive Src family tyrosine kinase inhibitor having a hydrophobic group that is less than about 6 angstroms in size situated adjacent to an ATP-mimicing heteroaromatic moiety. The Src family tyrosine kinase inhibitors can be used to prepare medicaments for the treatment of myocardial infarction. Also disclosed are articles of manufacture containing a chemical Src family tyrosine kinase inhibitor.
Patent CA-2558371-A1 (CA)
Title: Methods of modulating immune responses by modulating tim-1 and tim-4 function
Inventor: KUCHROO VIJAY K
IPC: C07K16/28
Filed: 2005-03-14
Abstract: The invention relates to methods of modulating immune responses in a subject, such as by administering to the subject agents which modulate tim-1, tim-2 or tim-4 activity, or which modulate the physical interaction between tim-1 and tim-4 or between tim-2 and a tim-2 ligand. Immune responses include, but are not limited to, autoimmune disorders, transplantation tolerance, and Thl and Th2-mediated responses and disorders. The invention also relates to novel assays for identifying agents which modulate the physical interaction between tim-1 and tim-4. In addition, the invention relates to novel soluble tim-4 polypeptides and to nucleic acids which encode them.
Patent CA-2558728-A1 (CA)
Inventor: CUMMING J STUART
IPC: A61F2/16
Filed: 1998-12-09
Abstract: An accommodating intraocular lens (32) to be implanted within the natural capsular bag (20) of a human eye from which the natural lens matrix has been removed through an anterior capsule opening in the bag circumferentially surrounded by an anterior capsular remnant (22). During a postoperative healing period following surgery, the anterior capsular remnant fuses to the posterior capsule of the bag by fibrosis (30) about haptics (36) on the implanted lens while the ciliary muscle is maintained in its relaxed state by a cycloplegic to prevent dislocation of the lens, and the lens is deflected rearwardly by the fibrosing anterior capsular remnant to a distant vision position against the elastic posterior capsule (24) of the bag in which the posterior capsule is stretched rearwardly. After fibrosis is complete, natural brain-induced contraction and relaxation of the ciliary muscle relaxes and stretches the fibrosed anterior remnant and increases and reduces vitreous pressure in the eye to effect vision accommodation by the remnant, the posterior capsule, and vitreous pressure. A method of utilizing the intraocular lens to provide a patient with vision accommodation.
Patent CA-2562572-A1 (CA)
Inventor: PISANO CLAUDIO
IPC: A61P35/04
Filed: 2005-05-04
Abstract: Compounds or formula (I) are described, in which R and R1 groups are as defined here below and include the condensation of the camptothecin molecule in position 20 with a cyclopeptide containing the RGD sequence. Said compounds are endowed both with high affinity for integrin receptors .alpha.v.beta.3 and .alpha.v.beta.5 and with selective cytotoxic activity on human tumor cell lines at micromolar concentrations.
Patent CA-2563518-A1 (CA)
Title: Multi-lineage progenitor cells
Inventor: COLLINS DANIEL P
IPC: C12N5/074
Filed: 2005-04-20
Abstract: Fetal blood multi-lineage progenitor cells that are capable of a wide spectrum of transdifferentiation are described.
Patent CA-2563797-A1 (CA)
Inventor: BROTHMAN ARTHUR R
IPC: G16B25/10
Filed: 2005-04-22
Abstract: The invention provides articles of manufacture which are arrays, reagents, kits, and methods for diagnosis and/or prognosis of diseases with genomic aberrations. The methods of the invention identify differences between DNA  samples from normal and disease tissues that are ascertained using comparative genomic hybridization (CGH) with microarrays of genomic fragments covering the whole genome of an organism, or microarrays containing subsets of the genome that are identified by the methods herein, for example, the long arm of chromosome 2 associated with prostate cancer. The detected genomic aberrations, are correlated to specific clinical outcomes, such that specific patterns of genomic aberration-disease association are identified in the majority of samples. The invention also provides genomic DNA arrays encompassing regions, the aberration of which was correlated to specific disease outcomes, for diagnosis/prognosis of such diseases.
Patent CA-2563968-A1 (CA)
Title: Neurogenic pain control agent composition
Inventor: OSAKI TAKASHI
IPC: C07D405/04
Filed: 2005-05-23
Abstract: A neurogenic pain control agent composition which contains either a compound represented by the formula (1) or a salt of the compound.
Patent CA-2565946-A1 (CA)
Title: Contact termination member for an electrical receptacle
Inventor: TIBERIO PATRICK J
IPC: H01R25/00
Filed: 2006-10-27
Abstract: A contact termination member for an electrical receptacle is provided that has a base. A first spring arm is connected to the base and has a first free end. A second spring arm is connected to the base and has a second free end. The first and second free ends are adapted to engage a wire received by the contact termination member. The first and second free ends are non-parallel. The first and second spring arms engage the inserted wire to securely retain the wire within the contact termination member.
Patent CA-2566618-A1 (CA)
Inventor: LIMBACK SCOTT R
IPC: A47L15/44
Filed: 2005-03-28
Abstract: A preferred embodiment dispenser (100) for dispensing product tablets includes a first disk member (112), a second disk member (120), and a third disk member (127). The first disk member is rotatable and includes a first aperture (114) exending longitudinally through the first disk member. The second disk member is stationary and includes a second aperture (123) extending longitudinally through the second disk member. The third disk member is rotatable and includes a third aperture (132) extending longitudinally through the third disk member. The second apperture is intermittently aligned with the first aperture and the third aperture. The first aperture and the third aperture being positioned at different locations with respect to the second aperture therby aligning with the second aperture at separate times resulting in an interrupted flow path for the product tablets.
Patent CA-2567810-A1 (CA)
Title: Cerberus/coco derivatives and uses thereof
Inventor: SEEHRA JASBIR
IPC: A61K38/18
Filed: 2005-05-27
Abstract: The invention relates to Cerberus/Dan/gremlin polypeptides or variants thereof for use in treating of disorders associated with myostatin, nodal and GDF-11.  Preferred polypeptides are Coco or Cerberus derivatives.
Patent CA-2569803-A1 (CA)
Title: Insert for ultrasonic burr-drill unit
Inventor: RICHER JEAN-MICHEL
IPC: A61C17/20
Filed: 2005-06-16
Abstract: The invention concerns an insert (130) comprising a cavity (131) forming a housing for a locating element (140) to enable the range of power and amplitude ultrasounds adapted for the ultrasonic insert (130) designed to be mounted on a surgical hand piece (120) to be selected. The locating element is made of an elastic material having a melting point higher than 130 ~C allowing it to resist to the vibrations as well as the sterilizing temperatures. The locating element (140) has a colour or design corresponding to the range of power and amplitude of the ultrasounds adapted to its use.
Patent CA-2571614-A1 (CA)
Title: Screening methods
Inventor: WARD MALCOLM
IPC: G01N33/68
Filed: 2005-06-21
Abstract: The present invention provides materials and methods relating to screening for compounds useful in the treatment of Alzheimer's disease and related conditions. In particular, screening methods using tyrosine kinases are provided, as are methods relating to the role of tyrosine kinases as therapeutic targets.
Patent CA-2572897-A1 (CA)
Title: Pharmaceutical composition for the treatment of bone fracture
Inventor: RYU JEI MAN
IPC: A61P19/00
Filed: 2005-07-05
Abstract: Disclosed herein is a composition for the treatment bone fracture comprising N-hydroxy-4-{5- [4- (5-isopropyl-2- methyl-1, 3-thiazol-4-yl)phenoxy] pentoxyl -benzamidine, 4-{5- [4- (5-isopropyl-2-methyl--l, 3-thiazol-4-yl)phenoxy]pentoxy}- benzamidine or pharmaceutically acceptable salts thereof as a medicinally effective ingredient. The composition of the present invention can significantly reduce the volume of bony callus, increase bony density and strength of bony callus, and decrease the contents of connective tissue and cartilage tissue in bony callus, and thus promote loss and ossification of the bony callus formed during the fracture healing process.  Therefore, the composition of the present invention is useful for the treatment of bone fracture.
Patent CA-2577905-A1 (CA)
Inventor: HARTMAN LUKE
IPC: B65D35/00
Filed: 2005-08-30
Abstract: A container assembly having a container, a fitment and a cap assembly. The container has at least one panel and at least one seal sealing the at least one panel to define a cavity. The fitment is coupled with the container, comprising a body having a first end and a second end. The second end extends away from the container, wherein the fitment provides fluid communication with the cavity. The cap assembly is releasably attachable to the second end of the fitment. The cap assembly comprises a base and a cover. The base includes an upper surface, a lower surface and an opening extending therethrough. The opening including an upper annular rim extending from the upper surface of the base and a lower annular rim extending from the lower surface of the base. The cover is attachable to the base to cover the opening. The cover includes an annular ring that extends along at least a portion of the upper annular rim of the opening and the lower annular rim of the opening. The annular ring forms a hermetic seal with at least one of the upper and lower annular rims of the opening.
Patent CA-2578675-A1 (CA)
Inventor: ROENNBLAD KAJ
IPC: E03D5/00
Filed: 2007-02-13
Abstract: A sewer system comprising a sewage receptacle, sewer piping connected to the sewage receptacle by means of a discharge valve, a vacuum generating means for generating vacuum in the sewer piping, and a control mechanism for controlling the discharge valve. In order to achieve a more rapid closing of the discharge valve after discharge of the sewage from the sewage receptacle, the vacuum sewer system further comprises an aeration means in direct fluid communication with the discharge valve. The control mechanism is arranged to control the aeration means. The present invention also relates to a discharge valve for such a vacuum sewer system.
Patent CA-2580800-A1 (CA)
Title: Disinfectant cap for sterile liquid dispenser
Inventor: WEBB GARTH T
IPC: A61J1/00
Filed: 2005-07-13
Abstract: A disinfectant cap for sterile liquid dispensers is disclosed. The cap for a dispenser for sterile liquid has a hollow container for storing the sterile liquid and a dispensing end having an outlet port, wherein the cap comprises a biocide-retaining element secured to the inner surface of the cap and is configured to contact the outlet port of the dispenser when in the closed position.
Patent CA-2581201-A1 (CA)
Inventor: JAKOB MARTIN
IPC: A23C19/11
Filed: 2005-08-26
Abstract: The invention relates to an aqueous polymer dispersion containing A) a polymer dispersion produced by radical polymerization of ethylenically unsaturated monomers, B) stabilizing suitable for carrying out radical polymerization, in addition to C) 0.01 - 20.000 wt. ppm, in relation to the mass of the total dispersion, of at least one compound of general formula la and/or lb wherein R1, R2, R13 and R14 independently represent hydrogen, C1-C6-alkyl, C1-C6-alkoxy, carboxy, nitrile, isonitrile, cyano or halogen, R3 - R12 and R15- R24 independently represent hydrogen and selected organic radicals, and wherein at least one of the substituents R3 - R12or R15 - R24 represents hydroxyl and/or alkoxy and/or alkanoyloxy. The aqueous polymer dispersion can be used to coat foodstuffs, as a dye or as an adhesive and the films thus obtained are characterized by high fungicidal resistance.
Patent CA-2583066-A1 (CA)
Inventor: REINDERS JOHANNES ANTONIUS MAR
IPC: F24F1/0007
Filed: 2004-10-18
Abstract: A heat exchange laminate comprises a formable carrier layer at least partially covered with a flexible liquid retaining layer having an open structure. By forming such a laminate of two layers, desired properties such as the spatial distribution of the liquid retaining layer, can be imparted to the heat exchange laminate prior to forming. The laminate may then be conveniently formed into any desired shape by known manufacturing procedures for incorporation into a heat exchanger. The laminate may be used to cool a first fluid by evaporation of a liquid into a second fluid operating at or near its saturation point.
Patent CA-2583550-A1 (CA)
Title: Thienopyridines as allosteric potentiators of the m4 muscarinic receptor
Inventor: RUBIO ESTEBAN ALMUDENA
IPC: A61P25/00
Filed: 2005-10-18
Abstract: The present invention relates to selective allosteric potentiators of the Formula (I): or pharmaceutically acceptable salts thereof, for the treatment of disorders associated with M4 muscarinic receptors.
Patent CA-2584497-A1 (CA)
Title: Leadless cardiac stimulation systems
Inventor: HASTINGS ROGER N
IPC: A61N1/05
Filed: 2005-10-19
Abstract: Various configurations of systems that employ leadless electrodes to provide pacing therapy are provided. In one example, a system that provides multiple sites for pacing of myocardium of a heart includes wireless pacing electrode assemblies that are implantable at sites proximate the myocardium using a percutaneous, transluminal, catheter delivery system. Also disclosed are various configurations of such systems, wireless electrode assemblies, and delivery catheters for delivering and implanting the electrode assemblies.
Patent CA-2586091-A1 (CA)
Title: Method and system for computing log-likelihood ratios for coded quadrature amplitude modulated signals
Inventor: ALLPRESS STEPHEN ALAN
IPC: H04J13/00
Filed: 2005-10-11
Abstract: According to an embodiment of the invention, a method and system is disclosed for determining log-likelihood ratios for a coded set of individual bits (40) of a quadrature amplitude modulation (QAM) codeword. In the method at most two constant values (33,35) may be determined to perform a set of predetermined functions, the output of each of function is based on the constant values and at least one received component corresponding to the code word, to determine log-likelihood ratios (37) for each individual bit of the set of individual bits of the codeword. The QAM codeword may correspond to at least a portion of a signal of a wireless device, such as a mobile third-generation device operating according to a Wideband Code-Division Multiple Access (WCDMA) standard.